Sign In
Buy MSOS
$4.74
-0.310 (-6.14%)
At Close: Jun 03, 2026
Pot stocks pop on Schedule 3 hopes: Tilray Brands, Trulieve Cannabis, Cresco Labs: How high will they go?
01:31pm, Wednesday, 17'th Dec 2025
Shares of publicly traded companies operating in the cannabis space continue to perform strongly as the Trump administration considers reclassifying marijuana.
Trump expected to sign executive order to fast-track reclassification of cannabis, NBC News reports
07:16pm, Tuesday, 16'th Dec 2025
U.S. President Donald Trump is expected to sign an executive order as soon as this week that would fast-track the reclassification of cannabis, NBC News reported on Tuesday, citing four people with di
Trump again says he is considering reclassifying marijuana as less dangerous drug
09:55pm, Monday, 15'th Dec 2025
President Donald Trump said he is considering an executive order to reclassify marijuana as Schedule III drug, citing research benefits and public demand for policy reform.
Trump Weighs Marijuana Changes: 'A Lot Of People Want To See It'
06:18pm, Monday, 15'th Dec 2025
President Donald Trump told reporters on Monday he is weighing an executive order to reclassify marijuana as a Schedule III substance.
Trump says he's 'strongly' considering reclassifying pot via executive order
04:28pm, Monday, 15'th Dec 2025
President Donald Trump confirmed he's considering an executive order loosening regulations on marijuana. Pot stocks fell on Monday as investors took profits following a record-setting session.
Trump says he is considering executive order to reclassify marijuana
03:53pm, Monday, 15'th Dec 2025
President Donald Trump said on Monday he is considering signing an executive order to reclassify marijuana as a less dangerous drug.
5 ETFs to Watch as Restrictions on Marijuana Set to Ease
04:28pm, Friday, 12'th Dec 2025
Cannabis stocks soared on Friday following news that U.S. president Donald Trump is expected to sign an executive order as soon as Monday that would ultimately ease federal restrictions on marijuana.
Cannabis stocks spike on reports Trump plans to ease federal pot restrictions
04:21pm, Friday, 12'th Dec 2025
The rally marked one of the biggest single-day moves for cannabis stocks in years, snapping a prolonged slump.
Cannabis stocks surge on Trump's rumored Schedule 3 marijuana change. How high can pot shares get?
04:11pm, Friday, 12'th Dec 2025
Multiple news reports this week said that President Trump is expected to reclassify marijuana's drug scheduling, which would lessen restrictions on its use and potentially allow companies that operate
Trump Expected to Label Pot a Less Dangerous Drug
02:21pm, Friday, 12'th Dec 2025
President Donald Trump is expected have his administration classify marijuana as a less dangerous drug, according to people familiar with the matter. This has been good news for pot stocks.
Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC
11:52am, Friday, 12'th Dec 2025
Cannabis stocks jumped Friday as the White House moved to significantly ease federal restrictions on marijuana. Brandon Gomez has the latest on the timing of a potential Executive Order and why the in
Best-Performing ETFs of Last Week
08:01am, Monday, 08'th Dec 2025
Cannabis, nat gas, space & meme ETFs surged last week: WEED, MSOS, UNG, UNL, UFO, XES & MEME led gains as rate-cut hopes lifted markets.
MSOS: Focused Exposure To U.S. Cannabis Stocks
08:47pm, Wednesday, 03'rd Dec 2025
The AdvisorShares Pure US Cannabis ETF offers concentrated, actively managed exposure to the US cannabis industry via equities and swaps. MSOS is top-heavy, with 97% of net assets in its top 10 positi
Marijuana ETFs Look to Supreme Court Legalization
04:02pm, Tuesday, 02'nd Dec 2025
Thematic ETFs have a long and storied history in the ETF ecosystem, offering investors ways to make sector bets, for example, or, craft a bespoke allocation with individual building blocks.
MSOS Has HEMP THC Prohibition Issues
09:05am, Tuesday, 02'nd Dec 2025
I maintain a Strong Sell on AdvisorShares Pure US Cannabis ETF due to excessive volatility and structural portfolio risks. MSOS is heavily concentrated, with 69% exposure to Curaleaf, Green Thumb Indu
